Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Samyang Holdings Corporation is a multifaceted conglomerate headquartered in South Korea. As a holding company, it oversees a diverse portfolio spanning various industries, including food production, pharmaceuticals, chemicals, and biotechnology. Founded in 1924, Samyang Holdings played a significant role in the growth of South Korea's economy, evolving from its origins in sugar production to become an influential entity in the global market. The corporation's food division is known for its production of noodles and other staple food items, catering not only to domestic but also international markets. Apart from food, Samyang's innovation in biodegradable plastics and other chemical products highlights its commitment to sustainability and cutting-edge technology. In the pharmaceutical sector, the company focuses on developing advanced drug delivery systems and health supplements, addressing both local and worldwide health demands. With its diverse business segments and continued emphasis on research and development, Samyang Holdings maintains a critical position in South Korea's industrial landscape, contributing to economic growth and technological advancement.
₩56,800.00
+₩700.00 (+1.25%)
Live · 05:26 PM
Operating margin is thin at 3.25%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 5.8% YoY. The question is whether this is cyclical or a structural shift.
Net debt of ₩546.74B represents 4.3x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
₩3.32T
▼ -5.8% YoY
Net Income (TTM)
-₩301.83B
▼ -433.1% YoY
Op. Margin
3.21%
▼ -0.3pp YoY
ROIC
2.00%
Cash Flow & Balance Sheet
FCF (TTM)
₩134.34B
▲ +3.2% YoY
Op. Cash Flow (TTM)
₩259.99B
▼ -45.2% YoY
Net Debt
₩546.74B
Cash & Equiv.
₩876.81B
3Y CAGR: +0.3%
Continue Research
Samyang Holdings (000070.XKRX) trades below a two-stage DCF intrinsic value of about KRW 891,810.06 per share, so at KRW 56,800.00 the stock looks undervalued (1,470.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Samyang Holdings scores 26/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 9.5%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about KRW 891,810.06 per share for 000070.XKRX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around KRW 668,857.54. At today's KRW 56,800.00, that puts the stock about 1,470.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Samyang Holdings scores 26 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 3.2% operating margin and a 2.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Samyang Holdings pays a regular dividend of about KRW 5,404.38 per share per year (typically in quarterly installments), a yield of roughly 9.5% at the current price. Samyang Holdings has grown the dividend at roughly 6.6% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For 000070.XKRX's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. 000070.XKRX currently trades below its estimated intrinsic value and scores 26/100 on quality (lower-quality). It also yields about 9.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.